Raymond Cobb, OD
Optometrist · Hamilton, ALNPI 1669463972
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Alcon at 52.4% of the total. That places this record below the midpoint for optometrist clinicians in AL, where the typical reported total is $902.
Across 12 payments — averaging $19.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$125
- Oyster Point Pharma, Inc.$28
- Tarsus Pharmaceuticals, Inc.$25
- Dompe US, Inc.$23
- Mallinckrodt Hospital Products Inc.$21
- Novartis$16
What the payments were for
- Food & beverage$238100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 7 | $125 |
| Oyster Point Pharma, Inc. | 1 | $28 |
| Tarsus Pharmaceuticals, Inc. | 1 | $25 |
| Dompe US, Inc. | 1 | $23 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
| Novartis | 1 | $16 |
How this compares
$238 in reported general payments places this provider in the 20th percentile of 749 optometrist providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 42 | $12,029 |
| CombiganBrimonidine Tartrate/Timolol | 37 | $7,202 |
| Cyclosporine | 14 | $6,970 |
| Loteprednol Etabonate | 37 | $6,772 |
| Latanoprost | 275 | $2,938 |
| Fluorometholone | 30 | $2,326 |
| Prednisolone Acetate | 36 | $1,538 |
| Timolol Maleate | 110 | $950 |
| Azelastine Hcl | 40 | $891 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 19 | $887 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 31 | $501 |
| Ketorolac Tromethamine | 12 | $202 |
| ErythromycinErythromycin Base | 16 | $173 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 12 | $156 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Hamilton
- Mark SchaefferHoover$470K
- Kelly NicholsBirmingham$231K
- Benjamin KachelmanFlorence$101K
- Neena JamesHuntsville$74K
- Tracey Schroeder SwartzHuntsville$69K
- Jack SchaefferHoover$60K
- Leo SemesBirmingham$60K
- Brooke KaplanMountain Brk$54K
- Patricia FulmerHuntsville$45K
- David SchaefferHoover$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.